Variant report
Variant | nsv975342 |
---|---|
Chromosome Location | chr11:59203908-59237268 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:61)
- CpG islands (count:488)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CCNT2 | chr11:59206222-59206375 | K562 | blood: | n/a | n/a |
2 | CEBPB | chr11:59235653-59235832 | K562 | blood: | n/a | n/a |
3 | CTCF | chr11:59230700-59230850 | HCPEpiC | choroid plexus: | n/a | n/a |
4 | CTCF | chr11:59230713-59230783 | GM19239 | blood: | n/a | n/a |
5 | CTCF | chr11:59230685-59230829 | Fibrobl | skin: | n/a | n/a |
6 | CTCF | chr11:59230659-59230860 | Gliobla | brain: | n/a | n/a |
7 | CTCF | chr11:59230740-59230890 | HUVEC | blood vessel: | n/a | n/a |
8 | CTCF | chr11:59230640-59230790 | HepG2 | liver: | n/a | n/a |
9 | CTCF | chr11:59230660-59230810 | HEK293 | kidney: | n/a | n/a |
10 | CTCF | chr11:59230699-59230841 | Hela-S3 | cervix: | n/a | n/a |
11 | CTCF | chr11:59230700-59230850 | HPAF | blood vessel: | n/a | n/a |
12 | CTCF | chr11:59230714-59230777 | HepG2 | liver: | n/a | n/a |
13 | CTCF | chr11:59230660-59230810 | HUVEC | blood vessel: | n/a | n/a |
14 | CTCF | chr11:59230679-59230747 | Lung_OC | lung: | n/a | n/a |
15 | CTCF | chr11:59230680-59230830 | WERI-Rb-1 | eye: | n/a | n/a |
16 | CTCF | chr11:59230680-59230830 | HCT-116 | colon: | n/a | n/a |
17 | CTCF | chr11:59230712-59230821 | ProgFib | skin: | n/a | n/a |
18 | CTCF | chr11:59230760-59230910 | GM12873 | blood: | n/a | n/a |
19 | CTCF | chr11:59230620-59230770 | HPAF | blood vessel: | n/a | n/a |
20 | CTCF | chr11:59230580-59230730 | HL-60 | blood: | n/a | n/a |
21 | CTCF | chr11:59230640-59230790 | HMF | breast: | n/a | n/a |
22 | CTCF | chr11:59230680-59230830 | AG10803 | skin: | n/a | n/a |
23 | CTCF | chr11:59230674-59230826 | HUVEC | blood vessel: | n/a | n/a |
24 | CTCF | chr11:59230664-59230865 | K562 | blood: | n/a | n/a |
25 | CTCF | chr11:59230706-59230832 | K562 | blood: | n/a | n/a |
26 | CTCF | chr11:59230827-59230830 | HUVEC | blood vessel: | n/a | n/a |
27 | E2F4 | chr11:59210259-59210431 | MCF10A-Er-Src | breast: | n/a | n/a |
28 | EGR1 | chr11:59220730-59220898 | K562 | blood: | n/a | chr11:59220798-59220807 chr11:59220834-59220845 chr11:59220832-59220847 |
29 | FOS | chr11:59230708-59231171 | HUVEC | blood vessel: | n/a | chr11:59230981-59230989 chr11:59230981-59230988 chr11:59230980-59230990 chr11:59230981-59230989 chr11:59230979-59230990 |
30 | FOS | chr11:59223863-59223913 | MCF10A-Er-Src | breast: | n/a | n/a |
31 | FOXA2 | chr11:59223139-59223310 | HepG2 | liver: | n/a | n/a |
32 | JUND | chr11:59225587-59225776 | HepG2 | liver: | n/a | chr11:59225628-59225639 chr11:59225629-59225638 |
33 | MAFF | chr11:59214434-59214735 | HepG2 | liver: | n/a | chr11:59214605-59214623 chr11:59214604-59214618 |
34 | MAFK | chr11:59214436-59214747 | HepG2 | liver: | n/a | chr11:59214603-59214619 chr11:59214604-59214618 chr11:59214608-59214617 chr11:59214601-59214621 chr11:59214607-59214617 |
35 | MAFK | chr11:59214421-59214754 | HepG2 | liver: | n/a | chr11:59214603-59214619 chr11:59214604-59214618 chr11:59214608-59214617 chr11:59214601-59214621 chr11:59214607-59214617 |
36 | MAFK | chr11:59214450-59214695 | IMR90 | lung: | n/a | chr11:59214603-59214619 chr11:59214604-59214618 chr11:59214608-59214617 chr11:59214601-59214621 chr11:59214607-59214617 |
37 | MAX | chr11:59230643-59230843 | H1-hESC | embryonic stem cell: | n/a | n/a |
38 | MYC | chr11:59230596-59230795 | MCF10A-Er-Src | breast: | n/a | n/a |
39 | MYC | chr11:59234977-59235051 | MCF10A-Er-Src | breast: | n/a | n/a |
40 | MYC | chr11:59236407-59236513 | MCF10A-Er-Src | breast: | n/a | n/a |
41 | POLR2A | chr11:59211388-59211508 | Gliobla | brain: | n/a | n/a |
42 | POLR2A | chr11:59225076-59225250 | A549 | lung: | n/a | n/a |
43 | POLR2A | chr11:59225054-59225071 | A549 | lung: | n/a | n/a |
44 | POLR2A | chr11:59223679-59223689 | MCF10A-Er-Src | breast: | n/a | n/a |
45 | RAD21 | chr11:59230606-59230874 | H1-hESC | embryonic stem cell: | n/a | n/a |
46 | RAD21 | chr11:59230591-59230875 | H1-hESC | embryonic stem cell: | n/a | n/a |
47 | RCOR1 | chr11:59210164-59210252 | HepG2 | liver: | n/a | n/a |
48 | SPI1 | chr11:59232054-59232336 | GM12891 | blood: | n/a | n/a |
49 | SPI1 | chr11:59232097-59232318 | K562 | blood: | n/a | n/a |
50 | SPI1 | chr11:59232169-59232286 | GM12878 | blood: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr11:59210634-59210684 | HRE | kidney: | n/a |
2 | chr11:59210634-59210684 | LNCaP | prostate: | n/a |
3 | chr11:59224044-59224094 | PANC-1 | pancreas: | n/a |
4 | chr11:59223996-59224046 | SKMC | muscle: | n/a |
5 | chr11:59224664-59224714 | K562 | blood: | n/a |
6 | chr11:59224044-59224094 | A549 | lung: | n/a |
7 | chr11:59210965-59211015 | HMEC | breast: | n/a |
8 | chr11:59223996-59224046 | HCF | heart: | n/a |
9 | chr11:59211431-59211481 | PrEC | prostate: | n/a |
10 | chr11:59211431-59211481 | HRCEpiC | kidney: | n/a |
11 | chr11:59209777-59209827 | HMEC | breast: | n/a |
12 | chr11:59224664-59224714 | AG09309 | skin: | n/a |
13 | chr11:59209775-59209825 | AG09319 | gingival: | n/a |
14 | chr11:59224664-59224714 | U87 | brain: | n/a |
15 | chr11:59211431-59211481 | Caco-2 | colon: | n/a |
16 | chr11:59209775-59209825 | HRE | kidney: | n/a |
17 | chr11:59224044-59224094 | HNPCEpiC | eye: | n/a |
18 | chr11:59209775-59209825 | HCM | heart: | n/a |
19 | chr11:59224044-59224094 | GM06990 | blood: | n/a |
20 | chr11:59224664-59224714 | PFSK-1 | brain: | n/a |
21 | chr11:59224044-59224094 | NHBE | bronchial: | n/a |
22 | chr11:59211431-59211481 | ECC-1 | luminal epithelium: | n/a |
23 | chr11:59209775-59209825 | GM06990 | blood: | n/a |
24 | chr11:59210634-59210684 | AoSMC | blood vessel: | n/a |
25 | chr11:59209777-59209827 | AG09319 | gingival: | n/a |
26 | chr11:59224664-59224714 | LNCaP | prostate: | n/a |
27 | chr11:59224044-59224094 | NHDF-neo | bronchial: | n/a |
28 | chr11:59209775-59209825 | HCF | heart: | n/a |
29 | chr11:59224044-59224094 | BJ | skin: | n/a |
30 | chr11:59210634-59210684 | AG04450 | lung: | fetal |
31 | chr11:59224664-59224714 | HRE | kidney: | n/a |
32 | chr11:59210965-59211015 | HCT-116 | colon: | n/a |
33 | chr11:59210634-59210684 | HNPCEpiC | eye: | n/a |
34 | chr11:59224044-59224094 | PFSK-1 | brain: | n/a |
35 | chr11:59223996-59224046 | HRPEpiC | eye: | n/a |
36 | chr11:59209775-59209825 | NH-A | brain: | n/a |
37 | chr11:59224044-59224094 | Jurkat | blood: | n/a |
38 | chr11:59209775-59209825 | Caco-2 | colon: | n/a |
39 | chr11:59224664-59224714 | HRPEpiC | eye: | n/a |
40 | chr11:59209775-59209825 | BE2_C | brain: | n/a |
41 | chr11:59210634-59210684 | CMK | blood: | n/a |
42 | chr11:59210634-59210684 | PrEC | prostate: | n/a |
43 | chr11:59210965-59211015 | Hepatocyte | liver: | n/a |
44 | chr11:59210965-59211015 | AoSMC | blood vessel: | n/a |
45 | chr11:59209777-59209827 | HEEpiC | esophagus: | n/a |
46 | chr11:59209777-59209827 | T-47D | breast: | n/a |
47 | chr11:59209777-59209827 | AG09309 | skin: | n/a |
48 | chr11:59209777-59209827 | HUVEC | blood vessel: | n/a |
49 | chr11:59211431-59211481 | MCF10A-Er-Src | breast: | n/a |
50 | chr11:59210965-59211015 | NT2-D1 | testis: | n/a |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
OR4D6 | TF binding region |
OR5A1 | TF binding region |
ENSG00000254640 | TF binding region |
OR4D6 | CpG island |
OR5A1 | CpG island |
ENSG00000254640 | CpG island |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs546193997 | chr11:59205205-59205206 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs17153714 | chr11:59205263-59205264 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs185524965 | chr11:59205291-59205292 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs540574700 | chr11:59205309-59205310 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs561851710 | chr11:59205315-59205316 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs529132137 | chr11:59205380-59205381 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs112376065 | chr11:59205398-59205399 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs145265631 | chr11:59205429-59205430 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs572793484 | chr11:59205441-59205442 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs72923323 | chr11:59205474-59205475 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs558334288 | chr11:59205502-59205503 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs191272143 | chr11:59205521-59205522 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs1026319 | chr11:59205522-59205523 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs142319807 | chr11:59205538-59205539 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs543574055 | chr11:59205569-59205570 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs183540150 | chr11:59205661-59205662 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs546923112 | chr11:59205702-59205703 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs568290928 | chr11:59205708-59205709 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs568489529 | chr11:59205719-59205720 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs1026320 | chr11:59205759-59205760 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs557001095 | chr11:59205771-59205772 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs2167923 | chr11:59205772-59205773 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs188325825 | chr11:59205796-59205797 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs10792241 | chr11:59206233-59206234 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs551226776 | chr11:59206313-59206314 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs560076002 | chr11:59206341-59206342 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs183872129 | chr11:59206343-59206344 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs545091113 | chr11:59207693-59207694 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs74883075 | chr11:59207735-59207736 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs563451147 | chr11:59207762-59207763 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs137941581 | chr11:59207772-59207773 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs527774031 | chr11:59207843-59207844 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs367741740 | chr11:59207854-59207855 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs549531413 | chr11:59207909-59207910 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs567641530 | chr11:59207978-59207979 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs574074615 | chr11:59208018-59208019 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs192647317 | chr11:59208027-59208028 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs550013401 | chr11:59208030-59208031 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs142499665 | chr11:59208070-59208071 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs538779304 | chr11:59208096-59208097 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs79057152 | chr11:59208105-59208106 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs184995010 | chr11:59208116-59208117 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs72923328 | chr11:59208173-59208174 | Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs116482311 | chr11:59208174-59208175 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs9787928 | chr11:59208179-59208180 | Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs530984146 | chr11:59208184-59208185 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs554267678 | chr11:59208195-59208196 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs138541956 | chr11:59208196-59208197 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs74958003 | chr11:59208206-59208207 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs563153211 | chr11:59208238-59208239 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Gastric cancer | 17908304 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Wilms tumour | 21544195 | CNVD |
Autism | 22495311 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Intellectual disability | 22102821 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 21637783 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Cervical cancer | 21063398 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Liposarcoma | 21253554 | CNVD |
Neuroblastoma | 18923524 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Breast cancer | 21364760 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Pituitary adenoma | 18645599 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 18632612 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Smith-Lemli-Opitz syndrome | 21572526 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Cancer | 16751803 | CNVD |
Seminomas | 18059402 | CNVD |
Autism | 22495309 | CNVD |
Autism | 20808228 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:59205200-59205800 | Enhancers | HUES48 Cell Line | embryonic stem cell |
2 | chr11:59207800-59208200 | Enhancers | Primary monocytes fromperipheralblood | blood |
3 | chr11:59208000-59208200 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
4 | chr11:59208000-59208400 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
5 | chr11:59211000-59211600 | Active TSS | Brain Substantia Nigra | brain |
6 | chr11:59219400-59219600 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |
7 | chr11:59219600-59220800 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
8 | chr11:59220800-59221000 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
9 | chr11:59222400-59224000 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
10 | chr11:59223600-59224200 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
11 | chr11:59224000-59226600 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
12 | chr11:59224200-59224400 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
13 | chr11:59224200-59229800 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
14 | chr11:59224400-59230600 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
15 | chr11:59228800-59230400 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
16 | chr11:59229800-59230400 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
17 | chr11:59230400-59231000 | Flanking Active TSS | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
18 | chr11:59230400-59231200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
19 | chr11:59230400-59231200 | Enhancers | HUVEC | blood vessel |
20 | chr11:59230600-59230800 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
21 | chr11:59230600-59231000 | Enhancers | Muscle Satellite Cultured Cells | -- |
22 | chr11:59230600-59231000 | Enhancers | Fetal Kidney | kidney |
23 | chr11:59230600-59231000 | Enhancers | NHDF-Ad | bronchial |
24 | chr11:59230600-59231200 | Enhancers | Ovary | ovary |
25 | chr11:59231000-59231800 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |